Patent Grant
9440036
1. Field of the Invention
The present invention relates generally to methods and system that provide oxygen enriched gas to a subject.
2. Description of the Related Art
There are many patients that require supplemental oxygen as part of Long Term Oxygen Therapy (LTOT). Currently, the vast majority of patients that are receiving LTOT are diagnosed under the general category of Chronic Obstructive Pulmonary Disease, COPD. This general diagnosis includes such common diseases as Chronic Asthma, Emphysema, Congestive Heart Failure and several other cardio-pulmonary conditions. Other people (e.g., obese individuals) may also require supplemental oxygen, for example, to maintain elevated activity levels.
Doctors may prescribe oxygen concentrators or portable tanks of medical oxygen for these patients. Usually a specific oxygen flow rate is prescribed (e.g., 1 liter per minute (LPM), 2 LPM, 3 LPM, etc.). Experts in this field have also recognized that exercise for these patients provide long term benefits that slow the progression of the disease, improve quality of life and extend patient longevity. Most stationary forms of exercise like tread mills and stationary bicycles, however, are too strenuous for these patients. As a result, the need for mobility has long been recognized. Until recently, this mobility has been facilitated by the use of small compressed oxygen tanks. The disadvantage of these tanks is that they have a finite amount of oxygen and they are heavy, weighing about 50 pounds, when mounted on a cart with dolly wheels.
Oxygen concentrators have been in use for about 50 years to supply patients suffering from respiratory insufficiency with supplemental oxygen. Traditional oxygen concentrators used to provide these flow rates have been bulky and heavy making ordinary ambulatory activities with them difficult and impractical. Recently, companies that manufacture large stationary home oxygen concentrators began developing portable oxygen concentrators, POCs. The advantage of POCs concentrators was that they can produce a theoretically endless supply of oxygen. In order to make these devices small for mobility, the various systems necessary for the production of oxygen enriched gas are condensed.
Systems and methods of providing an oxygen enriched gas to a user of an oxygen concentrator are described herein.
In one embodiment, a method of providing oxygen enriched gas to a user of an oxygen concentrator, includes: measuring the time between at least three successive breaths, wherein a breath is determined to begin when a drop in pressure is measured using a pressure sensor coupled to an outlet of a conduit coupling the user to an oxygen enriched gas source; determining an average breathing rate based on the time between each of the successive breaths, wherein the time between the penultimate breath and the last breath is not used to determine the average breathing rate; and setting an inspiration breath pressure threshold for the pressure sensor based on the determined average breathing rate. In an embodiment, the time is measured between six successive breaths. Adjusting the inspiration breath pressure threshold based on the average breathing rate, in some embodiments, is performed automatically. The oxygen enriched gas source may be an oxygen concentrator system or an oxygen tank.
In some embodiments, the threshold inspiration pressure is lowered when the determined average breathing rate changes from greater than 10 breaths per minute to less than 10 breaths per minute. In some embodiments, the threshold inspiration pressure is increased when the determined average breathing rate changes from less than 15 breaths per minute to greater than 15 breaths per minute. The inspiration breath pressure threshold may be maintained at a current setting when the average breathing rate is between about 10 breaths per minute and about 15 breaths per minute.
In some embodiments, the method further includes switching to an active mode, a sedentary mode, or remaining at the current mode based on the average breathing rate. For example, an active mode may be implemented when the average breathing rate comprises at least 15 breaths per minute. A sedentary mode may be activated when the average breathing rate comprises less than 10 breaths per minute.
In an embodiment, an oxygen concentrator apparatus includes: a pressure sensor, the pressure sensor configured to detect a breath pressure of a user; and a processor operable coupled to the pressure sensor. The processor is capable of executing non-transitory program instructions, wherein the program instructions are operable to: automatically measure the time between at least three successive breaths, wherein a breath is determined to begin when a drop in pressure is measured using the pressure sensor; determine an average breathing rate based on the time between each of the successive breaths, wherein the time between the penultimate breath and the last breath is not used to determine the average breathing rate; and set an inspiration breath pressure threshold for the pressure sensor based on the determined average breathing rate.
In another embodiment, a method of providing oxygen enriched gas to a user of an oxygen concentrator includes: determining a ratio of the change in absolute pressure during inhalation with respect to time, monitored over at least three breaths, wherein inhalation is determined to begin when a drop in pressure is measured using a pressure sensor coupled to an outlet of a conduit coupling the user to an oxygen enriched gas source; and adjusting an inspiration breath pressure threshold of the breath pressure sensor based on the ratio of the change in absolute pressure with respect to time. When determining the ratio, in some embodiments, the change in absolute pressure of the last breath is not used to determine the ratio. The oxygen enriched gas source may be an oxygen concentrator system or an oxygen tank.
Adjusting an inspiration breath pressure threshold of the pressure sensor based on the ratio includes adjusting the inspiration breath pressure threshold to a lower inspiration threshold breath pressure relative to a current inspiration breath pressure threshold if the ratio is negative. In an embodiment, adjusting an inspiration breath pressure threshold of the pressure sensor based on the ratio includes adjusting the inspiration breath pressure threshold to a lower inspiration threshold breath pressure relative to a current inspiration breath pressure threshold if the ratio is negative and less than or equal to −0.5.
Adjusting an inspiration breath pressure threshold of the pressure sensor based on the ratio includes adjusting the inspiration breath pressure threshold to a higher inspiration threshold breath pressure relative to a current inspiration breath pressure threshold if the ratio is positive. In an embodiment, adjusting an inspiration breath pressure threshold of the pressure sensor based on the ratio includes adjusting the inspiration breath pressure threshold to a higher inspiration threshold breath pressure relative to a current inspiration breath pressure threshold if the ratio is positive and greater than or equal to −0.5.
In some embodiments, the method further includes switching to an active mode, a sedentary mode, or remaining at the current mode based on the average breathing rate. For example, an active mode may be implemented when the ratio is positive. A sedentary mode may be activated when the ratio is negative.
In an embodiment, an oxygen concentrator apparatus includes: a pressure sensor configured to detect a breath pressure of a user; and a processor coupled to the pressure sensor. The processor is capable of executing non-transitory program instructions, wherein the program instructions are operable to: determine of a ratio of the change in absolute pressure during inhalation with respect to time, monitored over at least three breaths, wherein inhalation is determined to begin when a drop in pressure is measured using a pressure sensor coupled to an outlet of a conduit coupling the user to an oxygen enriched gas source; and adjust an inspiration breath pressure threshold of the breath pressure sensor based on the ratio of the change in absolute pressure with respect to time.
In an embodiment, a method of providing oxygen enriched gas to a user of an oxygen concentrator, includes: measuring the time between a plurality of successive breaths, wherein a breath is determined to begin when a drop in pressure is measured using a pressure sensor coupled to an outlet of a conduit coupling the user to an oxygen enriched gas source; creating groupings of breaths, wherein each grouping comprises at least three successive breaths; determining an average breathing rate for each grouping based on the time between each of the successive breaths within the grouping; and setting an inspiration breath pressure threshold for the pressure sensor based on the determined average breathing rate of two or more of the groupings.
In an embodiment, a method of providing oxygen enriched gas to a user of an oxygen concentrator, includes: measuring the time between a plurality of successive breaths, wherein a breath is determined to begin when a drop in pressure is measured using a pressure sensor coupled to an outlet of a conduit coupling the user to an oxygen enriched gas source; determining an average time between each of the successive breaths for at least three successive breaths, wherein the time between the penultimate breath and the last breath is not used to determine the average time; and setting an inspiration breath pressure threshold for the pressure sensor based on the determined average time.
Advantages of the present invention will become apparent to those skilled in the art with the benefit of the following detailed description of embodiments and upon reference to the accompanying drawings in which:
While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that the drawings and detailed description thereto are not intended to limit the invention to the particular form disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present invention as defined by the appended claims.
It is to be understood the present invention is not limited to particular devices or methods, which may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting. Headings are for organizational purposes only and are not meant to be used to limit or interpret the description or claims. As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include singular and plural referents unless the content clearly dictates otherwise. Furthermore, the word “may” is used throughout this application in a permissive sense (i.e., having the potential to, being able to), not in a mandatory sense (i.e., must). The term “include,” and derivations thereof, mean “including, but not limited to.”
The term “coupled” as used herein means either a direct connection or an indirect connection (e.g., one or more intervening connections) between one or more objects or components. The phrase “connected” means a direct connection between objects or components such that the objects or components are connected directly to each other. As used herein the phrase “obtaining” a device means that the device is either purchased or constructed.
Oxygen concentrators take advantage of pressure swing adsorption (PSA). Pressure swing adsorption involves using a compressor to increase gas pressure inside a canister that contains particles of a gas separation adsorbent. As the pressure increases, certain molecules in the gas may become adsorbed onto the gas separation adsorbent. Removal of a portion of the gas in the canister under the pressurized conditions allows separation of the non-adsorbed molecules from the adsorbed molecules. The gas separation adsorbent may be regenerated by reducing the pressure, which reverses the adsorption of molecules from the adsorbent. Further details regarding oxygen concentrators may be found, for example, in U.S. Published Patent Application No. 2009-0065007, published Mar. 12, 2009, and entitled “Oxygen Concentrator Apparatus and Method”, which is incorporated herein by reference.
Ambient air usually includes approximately 78% nitrogen and 21% oxygen with the balance comprised of argon, carbon dioxide, water vapor and other trace elements. If a gas mixture such as air, for example, is passed under pressure through a vessel containing a gas separation adsorbent bed that attracts nitrogen more strongly than it does oxygen, part or all of the nitrogen will stay in the bed, and the gas coming out of the vessel will be enriched in oxygen. When the bed reaches the end of its capacity to adsorb nitrogen, it can be regenerated by reducing the pressure, thereby releasing the adsorbed nitrogen. It is then ready for another cycle of producing oxygen enriched air. By alternating canisters in a two-canister system, one canister can be collecting oxygen while the other canister is being purged (resulting in a continuous separation of the oxygen from the nitrogen). In this manner, oxygen can be accumulated out of the air for a variety of uses include providing supplemental oxygen to patients.
Oxygen concentrator 100 may be a portable oxygen concentrator. For example, oxygen concentrator 100 may have a weight and size that allows the oxygen concentrator to be carried by hand and/or in a carrying case. In one embodiment, oxygen concentrator 100 has a weight of less than about 20 lbs., less than about 15 lbs., less than about 10 lbs., or less than about 5 lbs. In an embodiment, oxygen concentrator 100 has a volume of less than about 1000 cubic inches, less than about 750 cubic inches; less than about 500 cubic inches, less than about 250 cubic inches, or less than about 200 cubic inches.
Oxygen may be collected from ambient air by pressurizing ambient air in canisters 302 and 304, which include a gas separation adsorbent. Gas separation adsorbents useful in an oxygen concentrator are capable of separating at least nitrogen from an air stream to produce oxygen enriched gas. Examples of gas separation adsorbents include molecular sieves that are capable of separation of nitrogen from an air stream. Examples of adsorbents that may be used in an oxygen concentrator include, but are not limited to, zeolites (natural) or synthetic crystalline aluminosilicates that separate nitrogen from oxygen in an air stream under elevated pressure. Examples of synthetic crystalline aluminosilicates that may be used include, but are not limited to: OXYSIV adsorbents available from UOP LLC, Des Plaines, Iowa; SYLOBEAD adsorbents available from W. R. Grace & Co, Columbia, Md.; SILIPORITE adsorbents available from CECA S.A. of Paris, France; ZEOCHEM adsorbents available from Zeochem AG, Uetikon, Switzerland; and AgLiLSX adsorbent available from Air Products and Chemicals, Inc., Allentown, Pa.
As shown in
Compression system 200 may include one or more compressors capable of compressing air. In some embodiments, compression system may include one, two, three, four, or more compressors. Compression system 200 as depicted that includes compressor 210 and motor 220. Motor 220 is coupled to compressor 210 and provides an operating force to the compressor to operate the compression mechanism. Pressurized air, produced by compression system 200, may be forced into one or both of the canisters 302 and 304. In some embodiments, the ambient air may be pressurized in the canisters to a pressure approximately in a range of 13-20 pounds per square inch (psi). Other pressures may also be used, depending on the type of gas separation adsorbent disposed in the canisters.
In some embodiments, motor 220 is coupled to a pressurizing device (e.g. piston pump or a diaphragm pump). The pressuring device may be a piston pump that has multiple pistons. During operation, the pistons may be selectively turned on or off. In some embodiments, motor 220 may be coupled to multiple pumps. Each pump may be selectively turned on or off. For example, controller 400 may determine which pumps or pistons should be operated based on predetermined operating conditions.
Coupled to each canister 302/304 are inlet valves 122/124 and outlet valves 132/134. As shown in
In some embodiments, a two-step valve actuation voltage may be used to control inlet valves 122/124 and outlet valves 132/134. For example, a high voltage (e.g., 24 V) may be applied to an inlet valve to open the inlet valve. The voltage may then be reduced (e.g., to 7 V) to keep the inlet valve open. Using less voltage to keep a valve open may use less power (Power=Voltage*Current). This reduction in voltage minimizes heat buildup and power consumption to extend run time from the battery. When the power is cut off to the valve, it closes by spring action. In some embodiments, the voltage may be applied as a function of time that is not necessarily a stepped response (e.g., a curved downward voltage between an initial 24 V and a final 7 V).
In some embodiments, air may be pulled into the oxygen concentrator through compressors 305, 310. In some embodiments, air may flow from compressors 305, 310 to canisters 302, 304. In some embodiments, one of valves 122 or 124 may be closed (e.g., as signaled by controller 400) resulting in the combined output of both compressors 305, 310 lowing through the other respective valve 122 or 124 into a respective canister 302, 304. For example, if valve 124 is closed, the air from both compressors 305, 310 may flow through valve 122. If valve 122 is closed, the air from both compressors 305, 310 may flow through valve 124. In some embodiments, valve 122 and valve 124 may alternate to alternately direct the air from the compressors 305, 310 into respective canisters 302 or 304.
In an embodiment, pressurized air is sent into one of canisters 302 or 304 while the other canister is being vented. For example, during use, inlet valve 122 is opened while inlet valve 124 is closed. Pressurized air from compression system 200 is forced into canister 302, while being inhibited from entering canister 304 by inlet valve 124. In an embodiment, a controller 400 is electrically coupled to valves 122, 124, 132, and 134. Controller 400 includes one or more processors 410 operable to execute program instructions stored in memory 420. The program instructions are operable to perform various predefined methods that are used to operate the oxygen concentrator. Controller 400 may include program instructions for operating inlet valves 122 and 124 out of phase with each other, i.e., when one of inlet valves 122 or 124 is opened, the other valve is closed. During pressurization of canister 302, outlet valve 132 is closed and outlet valve 134 is opened. Similar to the inlet valves, outlet valves 132 and 134 are operated out of phase with each other. In some embodiments, the voltages and the duration of the voltages used to open the input and output valves may be controlled by controller 400.
Check valves 142 and 144 are coupled to canisters 302 and 304, respectively. Check valves 142 and 144 are one way valves that are passively operated by the pressure differentials that occur as the canisters are pressurized and vented. Check valves 142 and 144 are coupled to canisters to allow oxygen produced during pressurization of the canister to flow out of the canister, and to inhibit back flow of oxygen or any other gases into the canister. In this manner, check valves 142 and 144 act as one way valves allowing oxygen enriched gas to exit the respective canister during pressurization.
The term “check valve”, as used herein, refers to a valve that allows flow of a fluid (gas or liquid) in one direction and inhibits back flow of the fluid. Examples of check valves that are suitable for use include, but are not limited to: a ball check valve; a diaphragm check valve; a butterfly check valve; a swing check valve; a duckbill valve; and a lift check valve. Under pressure, nitrogen molecules in the pressurized ambient air are adsorbed by the gas separation adsorbent in the pressurized canister. As the pressure increases, more nitrogen is adsorbed until the gas in the canister is enriched in oxygen. The nonadsorbed gas molecules (mainly oxygen) flow out of the pressurized canister when the pressure reaches a point sufficient to overcome the resistance of the check valve coupled to the canister. In one embodiment, the pressure drop of the check valve in the forward direction is less than 1 psi. The break pressure in the reverse direction is greater than 100 psi. It should be understood, however, that modification of one or more components would alter the operating parameters of these valves. If the forward flow pressure is increased, there is, generally, a reduction in oxygen enriched gas production. If the break pressure for reverse flow is reduced or set too low, there is, generally, a reduction in oxygen enriched gas pressure.
In an exemplary embodiment, canister 302 is pressurized by compressed air produced in compression system 200 and passed into canister 302. During pressurization of canister 302 inlet valve 122 is open, outlet valve 132 is closed, inlet valve 124 is closed and outlet valve 134 is open. Outlet valve 134 is opened when outlet valve 132 is closed to allow substantially simultaneous venting of canister 304 while canister 302 is pressurized. Canister 302 is pressurized until the pressure in canister is sufficient to open check valve 142. Oxygen enriched gas produced in canister 302 exits through check valve and, in one embodiment, is collected in accumulator 106.
After some time the gas separation adsorbent will become saturated with nitrogen and will be unable to separate significant amounts of nitrogen from incoming air. This point is usually reached after a predetermined time of oxygen enriched gas production. In the embodiment described above, when the gas separation adsorbent in canister 302 reaches this saturation point, the inflow of compressed air is stopped and canister 302 is vented to remove nitrogen. During venting, inlet valve 122 is closed, and outlet valve 132 is opened. While canister 302 is being vented, canister 304 is pressurized to produce oxygen enriched gas in the same manner described above. Pressurization of canister 304 is achieved by closing outlet valve 134 and opening inlet valve 124. The oxygen enriched gas exits canister 304 through check valve 144.
During venting of canister 302, outlet valve 132 is opened allowing pressurized gas (mainly nitrogen) to exit the canister through concentrator outlet 130. In an embodiment, the vented gases may be directed through muffler 133 to reduce the noise produced by releasing the pressurized gas from the canister. As gas is released from canister 302, pressure in the canister drops. The drop in pressure may allow the nitrogen to become desorbed from the gas separation adsorbent. The released nitrogen exits the canister through outlet 130, resetting the canister to a state that allows renewed separation of oxygen from an air stream. Muffler 133 may include open cell foam (or another material) to muffle the sound of the gas leaving the oxygen concentrator. In some embodiments, the combined muffling components/techniques for the input of air and the output of gas may provide for oxygen concentrator operation at a sound level below 50 decibels.
During venting of the canisters, it is advantageous that at least a majority of the nitrogen is removed. In an embodiment, at least about 50%, at least about 60%, at least about 70%, at least about 80%, at least about 90%, at least about 95%, at least about 98%, or substantially all of the nitrogen in a canister is removed before the canister is re-used to separate oxygen from air. In some embodiments, a canister may be further purged of nitrogen using an oxygen enriched stream that is introduced into the canister from the other canister.
In an exemplary embodiment, a portion of the oxygen enriched gas may be transferred from canister 302 to canister 304 when canister 304 is being vented of nitrogen. Transfer of oxygen enriched gas from canister 302 to 304, during venting of canister 304, helps to further purge nitrogen (and other gases) from the canister. In an embodiment, oxygen enriched gas may travel through flow restrictors 151, 153, and 155 between the two canisters. Flow restrictor 151 may be a trickle flow restrictor. Flow restrictor 151, for example, may be a 0.009 D flow restrictor (e.g., the flow restrictor has a radius of 0.009 inches which is less than the diameter of the tube it is inside). Flow restrictors 153 and 155 may be 0.013 D flow restrictors. Other flow restrictor types and sizes are also contemplated and may be used depending on the specific configuration and tubing used to couple the canisters. In some embodiments, the flow restrictors may be press fit flow restrictors that restrict air flow by introducing a narrower diameter in their respective tube. In some embodiments, the press fit flow restrictors may be made of sapphire, metal or plastic (other materials are also contemplated).
Flow of oxygen enriched gas is also controlled by use of valve 152 and valve 154. Valves 152 and 154 may be opened for a short duration during the venting process (and may be closed otherwise) to prevent excessive oxygen loss out of the purging canister. Other durations are also contemplated. In an exemplary embodiment, canister 302 is being vented and it is desirable to purge canister 302 by passing a portion of the oxygen enriched gas being produced in canister 304 into canister 302. A portion of oxygen enriched gas, upon pressurization of canister 304, will pass through flow restrictor 151 into canister 302 during venting of canister 302. Additional oxygen enriched air is passed into canister 302, from canister 304, through valve 154 and flow restrictor 155. Valve 152 may remain closed during the transfer process, or may be opened if additional oxygen enriched gas is needed. The selection of appropriate flow restrictors 151 and 155, coupled with controlled opening of valve 154 allows a controlled amount of oxygen enriched gas to be sent from canister 304 to 302. In an embodiment, the controlled amount of oxygen enriched gas is an amount sufficient to purge canister 302 and minimize the loss of oxygen enriched gas through venting valve 132 of canister 302. While this embodiment describes venting of canister 302, it should be understood that the same process can be used to vent canister 304 using flow restrictor 151, valve 152 and flow restrictor 153.
The pair of equalization/vent valves 152/154 work with flow restrictors 153 and 155 to optimize the air flow balance between the two canisters. This may allow for better flow control for venting the canisters with oxygen enriched gas from the other of the canisters. It may also provide better flow direction between the two canisters. It has been found that, while flow valves 152/154 may be operated as bi-directional valves, the flow rate through such valves varies depending on the direction of fluid flowing through the valve. For example, oxygen enriched gas flowing from canister 304 toward canister 302 has a flow rate faster through valve 152 than the flow rate of oxygen enriched gas flowing from canister 302 toward canister 304 through valve 152. If a single valve was to be used, eventually either too much or too little oxygen enriched gas would be sent between the canisters and the canisters would, over time, begin to produce different amounts of oxygen enriched gas. Use of opposing valves and flow restrictors on parallel air pathways may equalize the flow pattern of the oxygen between the two canisters. Equalizing the flow may allow for a steady amount of oxygen available to the user over multiple cycles and also may allow a predictable volume of oxygen to purge the other of the canisters. In some embodiments, the air pathway may not have restrictors but may instead have a valve with a built in resistance or the air pathway itself may have a narrow radius to provide resistance.
At times, oxygen concentrator may be shut down for a period of time. When an oxygen concentrator is shut down, the temperature inside the canisters may drop as a result of the loss of adiabatic heat from the compression system. As the temperature drops, the volume occupied by the gases inside the canisters will drop. Cooling of the canisters may lead to a negative pressure in the canisters. Valves (e.g., valves 122, 124, 132, and 134) leading to and from the canisters are dynamically sealed rather than hermetically sealed. Thus, outside air may enter the canisters after shutdown to accommodate the pressure differential. When outside air enters the canisters, moisture from the outside air may condense inside the canister as the air cools. Condensation of water inside the canisters may lead to gradual degradation of the gas separation adsorbents, steadily reducing ability of the gas separation adsorbents to produce oxygen enriched gas.
In an embodiment, outside air may be inhibited from entering canisters after the oxygen concentrator is shut down by pressurizing both canisters prior to shut down. By storing the canisters under a positive pressure, the valves may be forced into a hermetically closed position by the internal pressure of the air in the canisters. In an embodiment, the pressure in the canisters, at shutdown, should be at least greater than ambient pressure. As used herein the term “ambient pressure” refers to the pressure of the surroundings that the oxygen generator is located (e.g. the pressure inside a room, outside, in a plane, etc.). In an embodiment, the pressure in the canisters, at shutdown, is at least greater than standard atmospheric pressure (i.e., greater than 760 mmHg (Torr), 1 atm, 101,325 Pa). In an embodiment, the pressure in the canisters, at shutdown, is at least about 1.1 times greater than ambient pressure; is at least about 1.5 times greater than ambient pressure; or is at least about 2 times greater than ambient pressure.
In an embodiment, pressurization of the canisters may be achieved by directing pressurized air into each canister from the compression system and closing all valves to trap the pressurized air in the canisters. In an exemplary embodiment, when a shutdown sequence is initiated, inlet valves 122 and 124 are opened and outlet valves 132 and 134 are closed. Because inlet valves 122 and 124 are joined together by a common conduit, both canisters 302 and 304 may become pressurized as air and or oxygen enriched gas from one canister may be transferred to the other canister. This situation may occur when the pathway between the compression system and the two inlet valves allows such transfer. Because the oxygen generator operates in an alternating pressurize/venting mode, at least one of the canisters should be in a pressurized state at any given time. In an alternate embodiment, the pressure may be increased in each canister by operation of compression system 200. When inlet valves 122 and 124 are opened, pressure between canisters 302 and 304 will equalize, however, the equalized pressure in either canister may not be sufficient to inhibit air from entering the canisters during shutdown. In order to ensure that air is inhibited from entering the canisters, compression system 200 may be operated for a time sufficient to increase the pressure inside both canisters to a level at least greater than ambient pressure. Regardless of the method of pressurization of the canisters, once the canisters are pressurized, inlet valves 122 and 124 are closed, trapping the pressurized air inside the canisters, which inhibits air from entering the canisters during the shutdown period.
An outlet system, coupled to one or more of the canisters, includes one or more conduits for providing oxygen enriched gas to a user. In an embodiment, oxygen enriched gas produced in either of canisters 302 and 304 is collected in accumulator 106 through check valves 142 and 144, respectively, as depicted schematically in
Turning to
Oxygen enriched gas in accumulator 106 passes through supply valve 160 into expansion chamber 170 as depicted in
The fluid dynamics of the outlet pathway, coupled with the programmed actuations of supply valve 160, results in a bolus of oxygen being provided at the correct time and with a flow profile that assures rapid delivery into the patient's lungs without any excessive flow rates that would result in wasted retrograde flow out the nostrils and into the atmosphere. It has been found, in our specific system, that the total volume of the bolus required for prescriptions is equal to 11 mL for each LPM, i.e., 11 mL for a prescription of 1 LPM; 22 mL for a prescription of 2 LPM; 33 mL for a prescription of 3 LPM; 44 mL for a prescription of 4 LPM; 55 mL for a prescription of 5 LPM; etc. This is generally referred to as the LPM equivalent. It should be understood that the LPM equivalent may vary between apparatus due to differences in construction design, tubing size, chamber size, etc.
Expansion chamber 170 may include one or more oxygen sensors capable of being used to determine an oxygen concentration of gas passing through the chamber. In an embodiment, the oxygen concentration of gas passing through expansion chamber 170 is assessed using oxygen sensor 165. An oxygen sensor is a device capable of detecting oxygen in a gas. Examples of oxygen sensors include, but are not limited to, ultrasonic oxygen sensors, electrical oxygen sensors, and optical oxygen sensors. In one embodiment, oxygen sensor 165 is an ultrasonic oxygen sensor that includes ultrasonic emitter 166 and ultrasonic receiver 168. In some embodiments, ultrasonic emitter 166 may include multiple ultrasonic emitters and ultrasonic receiver 168 may include multiple ultrasonic receivers. In embodiments having multiple emitters/receivers, the multiple ultrasonic emitters and multiple ultrasonic receivers may be axially aligned (e.g., across the gas mixture flow path which may be perpendicular to the axial alignment).
In use, an ultrasonic sound wave (from emitter 166) may be directed through oxygen enriched gas disposed in chamber 170 to receiver 168. Ultrasonic sensor assembly may be based on detecting the speed of sound through the gas mixture to determine the composition of the gas mixture (e.g., the speed of sound is different in nitrogen and oxygen). In a mixture of the two gases, the speed of sound through the mixture may be an intermediate value proportional to the relative amounts of each gas in the mixture. In use, the sound at the receiver 168 is slightly out of phase with the sound sent from emitter 166. This phase shift is due to the relatively slow velocity of sound through a gas medium as compared with the relatively fast speed of the electronic pulse through wire. The phase shift, then, is proportional to the distance between the emitter and the receiver and the speed of sound through the expansion chamber. The density of the gas in the chamber affects the speed of sound through the chamber and the density is proportional to the ratio of oxygen to nitrogen in the chamber. Therefore, the phase shift can be used to measure the concentration of oxygen in the expansion chamber. In this manner the relative concentration of oxygen in the accumulation chamber may be assessed as a function of one or more properties of a detected sound wave traveling through the accumulation chamber.
In some embodiments, multiple emitters 166 and receivers 168 may be used. The readings from the emitters 166 and receivers 168 may be averaged to cancel errors that may be inherent in turbulent flow systems. In some embodiments, the presence of other gases may also be detected by measuring the transit time and comparing the measured transit time to predetermined transit times for other gases and/or mixtures of gases.
The sensitivity of the ultrasonic sensor system may be increased by increasing the distance between emitter 166 and receiver 168, for example to allow several sound wave cycles to occur between emitter 166 and the receiver 168. In some embodiments, if at least two sound cycles are present, the influence of structural changes of the transducer may be reduced by measuring the phase shift relative to a fixed reference at two points in time. If the earlier phase shift is subtracted from the later phase shift, the shift caused by thermal expansion of expansion chamber 170 may be reduced or cancelled. The shift caused by a change of the distance between emitter 166 and receiver 168 may be the approximately the same at the measuring intervals, whereas a change owing to a change in oxygen concentration may be cumulative. In some embodiments, the shift measured at a later time may be multiplied by the number of intervening cycles and compared to the shift between two adjacent cycles. Further details regarding sensing of oxygen in the expansion chamber may be found, for example, in U.S. Published Patent Application No. 2009-0065007, published Mar. 12, 2009, and entitled “Oxygen Concentrator Apparatus and Method, which is incorporated herein by reference.
Flow rate sensor 185 may be used to determine the flow rate of gas flowing through the outlet system. Flow rate sensors that may be used include, but are not limited to: diaphragm/bellows flow meters; rotary flow meters (e.g. Hall Effect flow meters); turbine flow meters; orifice flow meters; and ultrasonic flow meters. Flow rate sensor 185 may be coupled to controller 400. The rate of gas flowing through the outlet system may be an indication of the breathing volume of the user. Changes in the flow rate of gas flowing through the outlet system may also be used to determine a breathing rate of the user. Controller 400 may control actuation of supply valve 160 based on the breathing rate and/or breathing volume of the user, as assessed by flow rate sensor 185
In some embodiments, ultrasonic sensor system 165 and, for example, flow rate sensor 185 may provide a measurement of an actual amount of oxygen being provided. For example, follow rate sensor 185 may measure a volume of gas (based on flow rate) provided and ultrasonic sensor system 165 may provide the concentration of oxygen of the gas provided. These two measurements together may be used by controller 400 to determine an approximation of the actual amount of oxygen provided to the user.
Oxygen enriched gas passes through flow meter 185 to filter 187. Filter 187 removes bacteria, dust, granule particles, etc. prior to providing the oxygen enriched gas to the user. The filtered oxygen enriched gas passes through filter 187 to connector 190. Connector 190 may be a “Y” connector coupling the outlet of filter 187 to pressure sensor 194 and outlet conduit 192. Pressure sensor 194 may be used to monitor the pressure of the gas passing through conduit 192 to the user. Changes in pressure, sensed by pressure sensor 194, may be used to determine a breathing rate of a user, as well as the onset of inhalation. Controller 400 may control actuation of supply valve 160 based on the breathing rate and/or onset of inhalation of the user, as assessed by pressure sensor 194. In an embodiment, controller 400 may control actuation of supply valve 160 based on information provided by flow rate sensor 185 and pressure sensor 194.
Oxygen enriched gas may be provided to a user through conduit 192. In an embodiment, conduit 192 may be a silicone tube. Conduit 192 may be coupled to a user using an airway coupling member 196, as depicted in
Canister System
Oxygen concentrator system 100 may include at least two canisters, each canister including a gas separation adsorbent. The canisters of oxygen concentrator system 100 may be disposed formed from a molded housing. In an embodiment, canister system 300 includes two housing components 310 and 510, as depicted in
As shown, valve seats 320, 322, 324, and 326 and air pathways 330 and 332 may be integrated into the housing component 310 to reduce the number of sealed connections needed throughout the air flow of the oxygen concentrator 100. In various embodiments, the housing components 310 and 410 of the oxygen concentrator 100 may form a two-part molded plastic frame that defines two canisters 302 and 304 and accumulation chamber 106.
Air pathways/tubing between different sections in housing components 310 and 510 may take the form of molded conduits. Conduits in the form of molded channels for air pathways may occupy multiple planes in housing components 310 and 510. For example, the molded air conduits may be formed at different depths and at different x, y, z positions in housing components 310 and 510. In some embodiments, a majority or substantially all of the conduits may be integrated into the housing components 310 and 510 to reduce potential leak points.
In some embodiments, prior to coupling housing components 310 and 510 together, O-rings may be placed between various points of housing components 310 and 510 to ensure that the housing components are properly sealed. In some embodiments, components may be integrated and/or coupled separately to housing components 310 and 510. For example, tubing, flow restrictors (e.g., press fit flow restrictors), oxygen sensors, gas separation adsorbents 139, check valves, plugs, processors, power supplies, etc. may be coupled to housing components 510 and 410 before and/or after the housing components are coupled together.
In some embodiments, apertures 337 leading to the exterior of housing components 310 and 410 may be used to insert devices such as flow restrictors. Apertures may also be used for increased moldability. One or more of the apertures may be plugged after molding (e.g., with a plastic plug). In some embodiments, flow restrictors may be inserted into passages prior to inserting plug to seal the passage. Press fit flow restrictors may have diameters that may allow a friction fit between the press fit flow restrictors and their respective apertures. In some embodiments, an adhesive may be added to the exterior of the press fit flow restrictors to hold the press fit flow restrictors in place once inserted. In some embodiments, the plugs may have a friction fit with their respective tubes (or may have an adhesive applied to their outer surface). The press fit flow restrictors and/or other components may be inserted and pressed into their respective apertures using a narrow tip tool or rod (e.g., with a diameter less than the diameter of the respective aperture). In some embodiments, the press fit flow restrictors may be inserted into their respective tubes until they abut a feature in the tube to halt their insertion. For example, the feature may include a reduction in radius. Other features are also contemplated (e.g., a bump in the side of the tubing, threads, etc.). In some embodiments, press fit flow restrictors may be molded into the housing components (e.g., as narrow tube segments).
In some embodiments, spring baffle 129 may be placed into respective canister receiving portions of housing component 310 and 510 with the spring side of the baffle 129 facing the exit of the canister. Spring baffle 129 may apply force to gas separation adsorbent 139 in the canister while also assisting in preventing gas separation adsorbent 139 from entering the exit apertures. Use of a spring baffle 129 may keep the gas separation adsorbent compact while also allowing for expansion (e.g., thermal expansion). Keeping the gas separation adsorbent 139 compact may prevent the gas separation adsorbent from breaking during movement of the oxygen concentrator system 100).
In some embodiments, pressurized air from the compression system 200 may enter air inlet 306. Air inlet 306 is coupled to inlet conduit 330. Air enters housing component 310 through inlet 306 travels through conduit 330, and then to valve seats 322 and 324.
In an embodiment, pressurized air is sent into one of canisters 302 or 304 while the other canister is being vented. For example, during use, inlet valve 122 is opened while inlet valve 124 is closed. Pressurized air from compression system 200 is forced into canister 302, while being inhibited from entering canister 304 by inlet valve 124. During pressurization of canister 302, outlet valve 132 is closed and outlet valve 134 is opened. Similar to the inlet valves, outlet valves 132 and 134 are operated out of phase with each other. Each inlet valve seat 322 includes an opening 375 that passes through housing 310 into canister 302. Similarly valve seat 324 includes an opening 325 that passes through housing 310 into canister 302. Air from conduit 330 passes through openings 323, or 325 if the respective valve (322 or 324) is open, and enters a canister.
Check valves 142 and 144 (See,
Oxygen enriched gas from either canister, travels through conduit 342 or 344 and enters conduit 346 formed in housing 310. Conduit 346 includes openings that couple the conduit to conduit 342, conduit 344 and accumulator 106. Thus oxygen enriched gas, produced in canister 302 or 304, travels to conduit 346 and passes into accumulator 106.
After some time the gas separation adsorbent will become saturated with nitrogen and will be unable to separate significant amounts of nitrogen from incoming air. When the gas separation adsorbent in a canister reaches this saturation point, the inflow of compressed air is stopped and the canister is vented to remove nitrogen. Canister 302 is vented by closing inlet valve 122 and opening outlet valve 132. Outlet valve 132 releases the vented gas from canister 302 into the volume defined by the end of housing 310. Foam material may cover the end of housing 310 to reduce the sound made by release of gases from the canisters. Similarly, canister 304 is vented by closing inlet valve 124 and opening outlet valve 134. Outlet valve 134 releases the vented gas from canister 304 into the volume defined by the end of housing 310.
While canister 302 is being vented, canister 304 is pressurized to produce oxygen enriched gas in the same manner described above. Pressurization of canister 304 is achieved by closing outlet valve 134 and opening inlet valve 124. The oxygen enriched gas exits canister 304 through check valve 144.
In an exemplary embodiment, a portion of the oxygen enriched gas may be transferred from canister 302 to canister 304 when canister 304 is being vented of nitrogen. Transfer of oxygen enriched gas from canister 302 to canister 304, during venting of canister 304, helps to further purge nitrogen (and other gases) from the canister. Flow of oxygen enriched gas between the canisters is controlled using flow restrictors and valves, as depicted in
Oxygen enriched gas in accumulator 106 passes through supply valve 160 into expansion chamber 170 which is formed in housing 510. An opening (not shown) in housing 510 couples accumulator 106 to supply valve 160. In an embodiment, expansion chamber may include one or more devices capable of being used to determine an oxygen concentration of gas passing through the chamber.
Controller System
Operation of oxygen concentrator system 100 may be performed automatically using an internal controller 400 coupled to various components of the oxygen concentrator system, as described herein. Controller 400 includes one or more processors 410 and internal memory 420, as depicted in
In some embodiments, controller 400 includes processor 410 that includes, for example, one or more field programmable gate arrays (FPGAs), microcontrollers, etc. included on a circuit board disposed in oxygen concentrator system 100. Processor 410 is capable of executing programming instructions stored in memory 420. In some embodiments, programming instructions may be built into processor 410 such that a memory external to the processor may not be separately accessed (i.e., the memory 420 may be internal to the processor 410).
Processor 410 may be coupled to various components of oxygen concentrator system 100, including, but not limited to compression system 200, one or more of the valves used to control fluid flow through the system (e.g., valves 122, 124, 132, 134, 152, 154, 160, or combinations thereof), oxygen sensor 165, pressure sensor 194, flow rate monitor 180, temperature sensors, fans, and any other component that may be electrically controlled. In some embodiments, a separate processor (and/or memory) may be coupled to one or more of the components.
Controller 400 is programmed to operate oxygen concentrator system 100 and is further programmed to monitor the oxygen concentrator system for malfunction states. For example, in one embodiment, controller 400 is programmed to trigger an alarm if the system is operating and no breathing is detected by the user for a predetermined amount of time. For example, if controller 400 does not detect a breath for a period of 75 seconds, an alarm LED may be lit and/or an audible alarm may be sounded. If the user has truly stopped breathing, for example, during a sleep apnea episode, the alarm may be sufficient to awaken the user, causing the user to resume breathing. The action of breathing may be sufficient for controller 400 to reset this alarm function. Alternatively, if the system is accidently left on when output conduit 192 is removed from the user, the alarm may serve as a reminder for the user to turn oxygen concentrator system 100 off.
Controller 400 is further coupled to oxygen sensor 165, and may be programmed for continuous or periodic monitoring of the oxygen concentration of the oxygen enriched gas passing through expansion chamber 170. A minimum oxygen concentration threshold may be programmed into controller 400, such that the controller lights an LED visual alarm and/or an audible alarm to warn the patient of the low concentration of oxygen.
Controller 400 is also coupled to internal power supply 180 and is capable of monitoring the level of charge of the internal power supply. A minimum voltage and/or current threshold may be programmed into controller 400, such that the controller lights an LED visual alarm and/or an audible alarm to warn the patient of low power condition. The alarms may be activated intermittently and at an increasing frequency as the battery approaches zero usable charge.
Further functions of controller 400 are described in detail in other sections of this disclosure.
A user may have a low breathing rate or depth if relatively inactive (e.g., asleep, sitting, etc.) as assessed by comparing the detected breathing rate or depth to a threshold. The user may have a high breathing rate or depth if relatively active (e.g., walking, exercising, etc.). An active/sleep mode may be assessed automatically and/or the user may manually indicate a respective active or sleep mode by a pressing button for active mode and another button for sleep mode. In some embodiments, a user may toggle a switch from active mode, normal mode, or sedentary mode. The adjustments made by the oxygen concentrator system in response to activating active mode or sleep mode are described in more detail herein.
Methods of Delivery of Oxygen Enriched Gas
The main use of an oxygen concentrator system is to provide supplemental oxygen to a user. Generally, the amount of supplemental oxygen to be provided is assessed by a physician. Typical prescribed amounts of supplemental oxygen may range from about 1 LPM to up to about 10 LPM. The most commonly prescribed amounts are 1 LPM, 2 LPM, 3 LPM, and 4 LPM. Generally, oxygen enriched gas is provided to the use during a breathing cycle to meet the prescription requirement of the user. As used herein the term “breathing cycle” refers to an inhalation followed by an exhalation of a person.
In order to minimize the amount of oxygen enriched gas that is needed to be produced to meet the prescribed amounts, controller 400 may be programmed to time delivery of the oxygen enriched gas with the user's inhalations. Releasing the oxygen enriched gas to the user as the user inhales may prevent unnecessary oxygen generation (further reducing power requirements) by not releasing oxygen, for example, when the user is exhaling. Reducing the amount of oxygen required may effectively reduce the amount of air compressing needed for oxygen concentrator 100 (and subsequently may reduce the power demand from the compressors).
Oxygen enriched gas, produced by oxygen concentrator system 100 is stored in an oxygen accumulator 106 and released to the user as the user inhales. The amount of oxygen enriched gas provided by the oxygen concentrator system is controlled, in part, by supply valve 160. In an embodiment, supply valve 160 is opened for a sufficient amount of time to provide the appropriate amount of oxygen enriched gas, as assessed by controller 400, to the user. In order to minimize the amount of oxygen required to meet the prescription requirements of a user, the oxygen enriched gas may be provided in a bolus when a user's inhalation is first detected. For example, the bolus of oxygen enriched gas may be provided in the first few milliseconds of a user's inhalation.
In an embodiment, pressure sensor 194 and/or flow rate sensor 185 may be used to determine the onset of inhalation by the user. For example, the user's inhalation may be detected by using pressure sensor 194. In use, a conduit for providing oxygen enriched gas is coupled to a user's nose and/or mouth (e.g., using a nasal cannula or a face mask). At the onset of an inhalation, the user begins to draw air into their body through the nose and/or mouth. As the air is drawn in, a negative pressure is generated at the end of the conduit, due, in part, to the venturi action of the air being drawn across the end of the delivery conduit. Pressure sensor 194 may be operable to create a signal when a drop in pressure is detected, to signal the onset of inhalation. Upon detection of the onset of inhalation, supply valve 160 is controlled to release a bolus of oxygen enriched gas from the accumulator 106.
In some embodiments, pressure sensor 194 may provide a signal that is proportional to the amount of positive or negative pressure applied to a sensing surface. The amount of the pressure change detected by pressure sensor 194 may be used to refine the amount of oxygen enriched gas being provided to the user. For example, if a large negative pressure change is detected by pressure sensor 194, the volume of oxygen enriched gas provided to the user may be increased to take into account the increased volume of gas being inhaled by the user. If a smaller negative pressure is detected, the volume of oxygen enriched gas provided to the user may be decreased to take into account the decreased volume of gas being inhaled by the user. A positive change in the pressure indicates an exhalation by the user and is generally a time that release of oxygen enriched gas is discontinued. Generally while a positive pressure change is sensed, valve 160 remains closed until the next onset of inhalation.
In some embodiments, the sensitivity of the pressure sensor 194 may be affected by the physical distance of the pressure sensor 194 from the user, especially if the pressure sensor is located in oxygen concentrator system 100 and the pressure difference is detected through the tubing coupling the oxygen concentrator system to the user. In some embodiments, the pressure sensor may be placed in the airway delivery device used to provide the oxygen enriched gas to the user. A signal from the pressure sensor may be provided to controller 400 in the oxygen concentrator 100 electronically via a wire or through telemetry such as through BLUETOOTH® (Bluetooth, SIG, Inc. Kirkland, Wash.) or other wireless technology.
In an embodiment, the user's inhalation may be detected by using flow rate sensor 185. In use, a conduit for providing oxygen enriched gas is coupled to a user's nose and/or mouth (e.g., using a nasal cannula or face mask). At the onset of an inhalation, the user begins to draw air into their body through the nose and/or mouth. As the air is drawn in, an increase in flow of gas passing through conduit is created. Flow rate sensor 185 may be operable to create a signal when an increase in flow rate is detected, to signal the onset of inhalation. Upon detection of the onset of inhalation, supply valve 160 is controlled to release a bolus of oxygen enriched gas from the accumulator 106.
A user breathing at a rate of 30 breaths per minute (BPM) during an active state (e.g., walking, exercising, etc.) may consume two and one-half times as much oxygen as a user who is breathing at 12 BPM during a sedentary state (e.g., asleep, sitting, etc.). Pressure sensor 194 and/or flow rate sensor 185 may be used to determine the breathing rate of the user. Controller 400 may process information received from pressure sensor 194 and/or flow rate sensor 185 and determine a breathing rate based on the frequency of the onset of inhalation. The detected breathing rate of the user may be used to adjust the bolus of oxygen enriched gas. The volume of the bolus of oxygen enriched gas may be increased as the users breathing rate increase, and may be decreased as the users breathing rate decreases. Controller 400 may automatically adjust the bolus based on the detected activity state of the user. Alternatively, the user may manually indicate a respective active or sedentary mode by selecting the appropriate option on the control panel of the oxygen concentrator. Alternatively, a user may operate controller 400 from a remote electronic device. For example, a user may operate the controller using a smart phone or tablet device.
In some embodiments, if the user's current activity level as assessed using the detected user's breathing rate exceeds a predetermined threshold, controller 400 may implement an alarm (e.g., visual and/or audio) to warn the user that the current breathing rate is exceeding the delivery capacity of the oxygen concentrator system. For example, the threshold may be set at 20 breaths per minute.
Methods of determining the breathing rate of a user typically count the number of breathes taken by the user over a pre-determined time and calculate the breathing rate. When determining the breathing rate of a user, all breaths measured during the pre-determined time period are typically used to calculate the breathing rate. Such a method, however, can lead to significant errors due to sudden changes in the breathing rate of the user. For example, while sleeping it is know that the times between breaths may vary greatly for an individual. Breathing patterns normally change during sleep. During deep sleep, breathing slows and becomes lighter as the body rests. During light sleep and REM, breathing can resemble breathing patterns of the person when awake. Periods of heavy breathing may also occur during dreams. Changes in breathing rate can occur quickly while a user is sleeping and even during awake periods. If the delivery of oxygen enriched gas is not adapted to the breathing patterns of the user properly, oxygen enriched gas may be wasted, by providing the oxygen enriched gas for too long, or may be insufficient, if the oxygen enriched gas is provided for too short a period.
Attempts have been made to take into account the erratic breathing of a user. For example, U.S. Pat. No. 7,841,343 to Deane et al. (“Deane”) described the use of a blind time to help compensate for erratic breathing. Specifically, Deane teaches that after a bolus of oxygen enriched gas is delivered to a user, a controller enters a blind time. During this blind time the controller will not accept any triggers to deliver oxygen enriched gas. This time may range from 0.5 to 3 seconds after the bolus is delivered. After this blind time has elapsed the controller sets the inspiration breath pressure threshold to a low level and gradually increases the sensitivity until a breath is detected. According to Deane, this helps to vary the bolus delivery in response to changes in the users breathing.
The method of Deane relies on a blind time in which no breaths are detected. Thus, if the user starts breathing rapidly, shortly after the delivery of a bolus of oxygen enriched gas, the method of Deane may be delayed in reacting to the change in breathing. In the worst case scenario, the user may change to a breathing rate in which every other breath falls within the blind time, leading to the false indication that the user is breathing at a breathing rate that is half the actual breathing rate. Such a situation can lead to oxygen depravity in the individual due to an insufficient amount of oxygen being supplied to the user.
Applicant has devised an improved method of determining a breathing rate, and controlling the inspiration breath pressure threshold based on the determined breathings. In an embodiment, the controller determines the breathing rate based on measuring a predetermined number of breaths (at least three) and discarding information related to the last breath measured. In this method the time between the penultimate breath and the last breath is not used to determine the average breathing rate. The breathing rate, determined using the information collected from the remaining breaths, was found to give a more accurate indication of the current breathing rate of the user. Such a method also provides a way to take into account erratic breathing patterns without having to resort to the extreme measure of creating artificial “blind times,” as discussed in Deane.
Over a period of time, controller 400 may collect and store the number of breaths. Based on the number of breaths, or the average time between breaths, over the period of time a breathing rate may be calculated. In some embodiments, the period of time is divided into equal time units. The number of breaths, or the average time between breaths, is determined in each time unit for the set period of time. The number of breaths, or average time between breaths, per time unit is used to determine a breathing rate. In some embodiments, the breathing rate in the last time unit is not used to determine if the delivery parameters should be changed. For example, if a period of time is broken up into 5 equal time units, the breathing rate determined for the last time unit is not used to determine an average breathing rate (for example, average breaths per minute).
For example, controller 400 may collect the number of breaths over a 5 minute period of time. During the 5 minutes, a user may have a breathing rate of 15 breaths per minute (“BPM”) for the first minute of the 5 minute time period, 10 BPM during the second minute of the 5 minute time period, 25 BPM during the third minute of the 5 minute time period, 30 BPM during the fourth minute of the 5 minute time period, and 40 BPM during the fifth minute of the 5 minute time period. The 40 BPM may be ignored and the remaining breaths averaged (for example, to determine an average breathing rate of 20 BPM. The breathing rate determined during the last minute of the 5 minute time period may be used for averaging of the next 5 minute time period. For example the last minute of the 5 minute time period may be used as the first minute of the next five minute time period. Alternatively, the five minute time period analyzed may be shifted by a minute. In this case, the second minute of the five minute period just analyzed becomes the first minute of the next five minute period. The fifth minute (ignored in the first breathing rate analysis), becomes the fourth minute of the next breathing rate analysis. In either case the last minute is ignored in the breathing rate analysis.
In another embodiment, the breathing rate may be determined by monitoring the time between each breath for at least three breaths. In some embodiments, the times between each of four, five, six, seven, eight, nine, ten, fifteen, sixteen, seventeen, or twenty successive breaths are measured and used to determine an average breathing rate. In this method the time between the penultimate breath and the last breath is ignored, with the breathing rate based on the time between the breaths up to the penultimate breath. For example, if 5 successive breaths are used to determine a breathing rate, the time between the 4th and 5th breath is discarded when determining the breathing rate. For example if the following times between breaths are obtained: 1st-2nd: 4.5 sec., 2nd-3rd: 4.7 sec, 3rd-4th—4.2 sec, 4th-5th: 5.2 sec, the average time between breaths is determined by averaging the first three times (4.5 sec, 4.7 sec, and 4.2 sec) and ignoring the last breath (5.2 sec). In this manner the average time between breaths is 4.47, giving an average breathing rate of 13.4 breathes per minute.
Using the average breathing rate, the inspiration breath pressure threshold may be adjusted relative to the current inspiration breath pressure threshold. Controller 400 may determine that the average breathing rate has changed from less than 15 breaths per minute to greater than 15 breaths per minute. Controller 400 may send an electronic signal to pressure sensor 194 that raises the threshold breath pressure inspiration relative to the current inspiration breath pressure threshold. When the determined average breathing rate changes from greater than 10 breaths per minute to less than 10 breaths per minute, controller 400 may send an electronic signal to the pressure sensor 194 that lowers the inspiration breath pressure threshold relative to the current inspiration breath pressure threshold. Controller 400 may determine that the average breathing rate is between 10 breaths per minute and 15 breaths per minute, and determine that no change in the current inspiration breath pressure threshold is necessary. If the average breathing rate is less than 5 breaths per minute then controller 400 may trigger an alarm. If the inspiration breath pressure threshold has been lowered relative to the current inspiration breath pressure threshold and no inspiration breath pressure is detected after a period of time (for example, 75 seconds), then controller 400 may trigger an alarm.
In another embodiment, the change in the inspiration breath pressure threshold may be adjusted by looking at the change in breathing rate over a predetermined period of time. For example, a change in breathing rate can be monitored by creating successive groupings of three or more breaths. For each successive grouping of three or more breaths, the breathing rate is determined (e.g., by calculating the breathing rate based on an average time between each breath in the grouping). The breathing rate from each grouping is compared to the next grouping to determine how the breathing rate is changing. If the breathing rate is increasing over three or more successive groupings (e.g., the breathing rate increases in at least two of the groupings), the controller may increase the inspiration breath pressure threshold. If the breathing rate is decreasing over three or more successive groupings (e.g., the breathing rate decreases in at least two of the groupings), the controller may lower the inspiration breath pressure threshold.
In a specific example, the time between each of seventeen successive breaths is measured. The breaths are then divided into four groupings, with each grouping having the inhalation times for four successive breaths. The groupings would then look as shown below, the number in parenthesis refers to the time between the breaths:
The last time (the time between breath 16 and 17, is not used to determine the breathing rate. In the above example, the first grouping (breaths 1-4) exhibits a breathing rate of 12 BPM. The second grouping exhibits a breathing rate of 17 BPM, which shows that the subjects breathing rate is increasing. Instead of changing the inspiration breath pressure threshold, the controller goes into a “watch” mode. In the “watch” mode the controller is alerted that a change in the inspiration breath pressure threshold may be needed. The controller then looks at the third grouping. The third grouping exhibits a breathing rate of 18 BPM. A breathing rate that is within +/−2 of the previous breathing rate, is not considered to have changed. Since the breathing rate has not changed (as defined above) from the second grouping to the third grouping, the controller remains in watch mode. The controller then looks at the change between the third and fourth groupings. The fourth grouping exhibits a breathing rate of 25 BPM. Since the controller has now seen a second increase among the four groupings measured, the controller increase the inspiration breath pressure threshold. The controller will continue to take additional groupings (in this example, of four successive breaths, excluding the last breath taken) and continue to evaluate whether the inspiration breath pressure threshold should be adjusted.
In some embodiments, rather than ignoring the last breath, the last grouping is ignored. For example, in the above example, the controller bases the decision to change the inspiration breath pressure threshold based on the first three groupings, ignoring the last (4th) grouping. Under these circumstances, the inspiration breath pressure threshold is not changed until additional groupings are taken and it is determined if the increase in breathing rate is continued.
In alternate embodiments, the controller may base decisions on the actual BPM rather than the change in BPM. For example, if the BPM changes to less than 10 breaths per minute in a grouping, the controller may go into a watch mode. If the BPM remains below 10 BPM in one of the next two groupings, the controller may send an electronic signal to the pressure sensor that lowers the inspiration breath pressure threshold relative to the current inspiration breath pressure threshold. If the BPM is between 10 breaths per minute and 15 breaths per minute, then no change is made to the inspiration breath pressure threshold. If the BPM changes to more than 15 breaths per minute in a grouping, the controller may go into a watch mode. If the BPM remains above 15 BPM in one of the next two groupings, the controller may send an electronic signal to the pressure sensor that increase the inspiration breath pressure threshold relative to the current inspiration breath pressure threshold. In this embodiment, as discussed above, the last breath detected or the last grouping measured may be ignored when determining if the inspiration breath pressure threshold should be changed.
In some embodiments, it is not necessary to calculate the breathing rate, but instead the time between breaths may be used in a decision making process. A flow chart of a process of adjusting the inspiration breath pressure threshold is shown in
If the average time between breaths of the subject is greater than the active state time, the controller compares the time to an inactive state time. In one embodiment, the subject is considered to be in an inactive state if the average time between breaths is greater than 6 seconds. It should be understood that other times can be used. If the average time between breaths of the subject is greater than 6 seconds, the controller sets the inspiration breath pressure threshold to a low pressure. If the average time between breaths of the subject is between 4 and 6 seconds, the controller does not change the inspiration breath pressure threshold.
As shown in
In some embodiments, controller 400 may send a signal to adjust pressure sensor 194 to adjust the threshold inspiration breath pressure based on the ratio of the change in absolute pressure with respect to time monitored over at least three breaths. In some embodiments, the change in absolute pressure with respect to time between each of four, five, six, seven, eight, nine, ten, fifteen or twenty successive breaths are measured and used to determine a ratio of change in absolute pressure with respect to time. Controller 400 may determine a ratio of the change in absolute pressure with respect to time based during a breathing period and store the information in a non-transitory medium. Based on the determined ratio between the change in absolute pressure with respect to time, controller 400 may send an electronic signal to breath pressure sensor 194 that adjusts the inspiration breath pressure threshold. If ratio is assessed to be negative, and less than, or equal to, −0.5 controller 400 may send an electronic signal to breath pressure sensor 194 that lowers the inspiration breath pressure threshold relative to the current inspiration breath pressure threshold. For example, if the ratio is assessed to be about −1.5 to about −0.5, (i.e., less than or equal to −0.5), controller 400 may send an electronic signal to breath pressure sensor 194 that lowers the inspiration breath pressure threshold relative to the current inspiration breath pressure threshold. If the ratio is assessed to be slightly positive or slightly negative (e.g., between −0.5 to +0.5), controller 400 may send an electronic signal to breath pressure sensor 194 that keeps the inspiration breath pressure threshold the same as the current inspiration breath pressure threshold. If the ratio is positive, and, for example, greater than or equal to +0.5, for example, controller 400 may send an electronic signal to breath pressure sensor 194 that raises the inspiration breath pressure threshold relative to the current inspiration breath pressure threshold.
In some embodiments, controller 400 may operate the oxygen concentrator based on the change in the inspiration breath pressure threshold. The frequency and/or duration of the provided oxygen enriched gas to the user relative to the current frequency and/or duration may be adjusted based on the change in the inspiration breath pressure threshold. Upon determining that the inspiration breath pressure threshold has been lowered, the controller 400 may switch the oxygen concentrator to a sedentary mode. Controller 400 may switch the oxygen concentrator to an active mode, when the inspiration breath pressure threshold has been raised.
In some embodiments, as seen in
In some embodiments, the sensitivity of the oxygen concentrator 100 may be selectively attenuated to reduce false inhalation detections due to movement of air from a different source (e.g., movement of ambient air). For example, the oxygen concentrator 100 may have two selectable modes—an active mode and an inactive mode. In some embodiments, the user may manually select a mode (e.g., through a switch or user interface). In some embodiments, the mode may be automatically selected by the oxygen concentrator 100 based on a detected breathing rate. For example, the oxygen concentrator 100 may use the pressure sensor 194 to detect a breathing rate of the user. If the breathing rate is above a threshold, the oxygen concentrator 100 may operate in an active mode (otherwise, the oxygen concentrator may operate in an inactive mode). Other modes and thresholds are also contemplated.
In some embodiments, in active mode, the sensitivity of the pressure sensor 194 may be mechanically, electronically, or programmatically attenuated. For example, during active mode, controller 400 may look for a greater pressure difference to indicate the start of a user breath (e.g., an elevated threshold may be compared to the detected pressure difference to determine if the bolus of oxygen should be released). In some embodiments, the pressure sensor 194 may be mechanically altered to be less sensitive to pressure differences. In some embodiments, an electronic signal from the pressure sensor may be electronically altered to ignore small pressure differences. This can be useful when in active mode. In some embodiments, during the inactive mode the sensitivity of the pressure sensor may be increased. For example, the controller 400 may look for a smaller pressure difference to indicate the start of a user breath (e.g., a smaller threshold may be compared to the detected pressure difference to determine if the bolus of oxygen should be released). In some embodiments, with increased sensitivity, the response time for providing the bolus of oxygen during the user's inhalation may be reduced. The increased sensitivity and smaller response time may reduce the size of the bolus necessary for a given flow rate equivalence. The reduced bolus size may also reduce the size and power consumption of the oxygen concentrator 100.
Providing a Bolus Based on Inhalation Profile
In an embodiment, the bolus profile can be designed to match the profile of a particular user. To do so, an inhalation profile may be generated based on information gathered from pressure sensor 194 and flow rate sensor 185. An inhalation profile is assessed based on, one or more of the following parameters: the breathing rate of the user; the inhalation volume of the user; the exhalation volume of the user; the inhalation flow rate of the user; and the exhalation flow rate of the user. The breathing rate of the user may be assessed by detecting the onset of inhalation using pressure sensor 194 or flow rate sensor 185 as previously discussed. Inhalation volume may be assessed by measuring the change in pressure during inhalation and calculating or empirically assessing the inhalation volume based on the change in pressure. Alternatively, inhalation volume may be assessed by measuring the flow rate during inhalation and calculating or empirically assessing the inhalation volume based on the flow rate and the length of the inhalation. Exhalation volume may be assessed in a similar manner using either positive pressure changes during exhalation, or flow rate and exhalation time. Inhalation flow rate of the user is measured from shortly after the onset of inhalation. Detection of the end of inhalation may be from the pressure sensor or the flow rate sensor. When onset of inhalation is detected by the pressure sensor, the onset is characterized by a drop in pressure. When the pressure begins to increase, the inhalation is considered complete. When onset of inhalation is detected by the flow rate sensor, the onset is characterized by an increase in the flow rate. When the flow rate begins to decrease, the inhalation is considered complete.
There is a minimum amount of oxygen necessary for a person to remain conscious. A person who is breathing rapidly is bringing in a lower volume of air in each breath, and thus, requires less oxygen enriched gas per inhalation. While there is some variation from patient to patient, this relationship can be used to establish the mean flow rate for each breath mathematically. By measuring a large population of patients, the profile of the relative flow from onset of inhalation to the onset of exhalation may be established. Using this flow profile as a template, the calculated actual flow based on breathing rate can be adjusted mathematically to a calculated actual flow profile. This profile can be used to adjust the opening and closing of the delivery valve to create an idealized profile for the patient based on their breathing rate. Inhalation profile data gathered from a population of users may be used to create an algorithm that makes the appropriate adjustments based on the detected inhalation profile. Alternatively, a look up table may be used to control valve actuation durations and pulse quantities based on a detected inhalation profile.
Measuring the inhalation profile of the patient provides a more accurate basis for control of the bolus of oxygen enriched gas being provided to the patient. For example, basing the delivery of oxygen enriched gas on the onset of inhalation may not take into account differences between individual users. For example, people having a similar breathing rate can have different inhalation/exhalation volume, inhalation/exhalation flow rates and, thus, different bolus requirements necessary to produce the prescribed amount of oxygen. In one embodiment, an inhalation profile is created based on the flow rate of air during inhalation and the duration of inhalation. The inhalation profile can then be used as a predictor of the volume of air taken in by a specific user during inhalation. Thus, inhalation profile information can be used to modify the amount of oxygen enriched air provided to the user to ensure that the prescribed level of oxygen is received. The amount of oxygen provided to a user may be adjusted by modifying the frequency and or duration of release of oxygen enriched gas from the accumulator with supply valve 160. By tracking the inhalation profile of the patient controller adjusts the delivery supply valve actuation to idealize the bolus profile to provide the oxygen at the maximum rate without causing wasteful retrograde flow.
In this patent, certain U.S. patents, U.S. patent applications, and other materials (e.g., articles) have been incorporated by reference. The text of such U.S. patents, U.S. patent applications, and other materials is, however, only incorporated by reference to the extent that no conflict exists between such text and the other statements and drawings set forth herein. In the event of such conflict, then any such conflicting text in such incorporated by reference U.S. patents, U.S. patent applications, and other materials is specifically not incorporated by reference in this patent.
Further modifications and alternative embodiments of various aspects of the invention may be apparent to those skilled in the art in view of this description. Accordingly, this description is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the general manner of carrying out the invention. It is to be understood that the forms of the invention shown and described herein are to be taken as embodiments. Elements and materials may be substituted for those illustrated and described herein, parts and processes may be reversed, and certain features of the invention may be utilized independently, all as would be apparent to one skilled in the art after having the benefit of this description of the invention. Changes may be made in the elements described herein without departing from the spirit and scope of the invention as described in the following claims.
This application claims priority to U.S. Provisional Application Ser. No. 61/713,254 entitled “Oxygen Concentrator Systems and Methods for Oral Delivery of Oxygen Enriched Air” filed Oct. 12, 2012, which is incorporated herein by reference in its entirety; and U.S. Provisional Application Ser. No. 61/804,365 entitled “Method and Systems for the Delivery of Oxygen Enriched Gas” filed Mar. 22, 2013, which is incorporated herein by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3584618 | Reinhard | Jun 1971 | A |
| 3768468 | Cox | Oct 1973 | A |
| 4194890 | McCombs et al. | Mar 1980 | A |
| 4215798 | Acharya | Aug 1980 | A |
| 4302224 | McCombs et al. | Nov 1981 | A |
| 4331455 | Sato | May 1982 | A |
| 4342573 | McCombs et al. | Aug 1982 | A |
| 4349357 | Russell | Sep 1982 | A |
| 4491459 | Pinkerton | Jan 1985 | A |
| 4519387 | Durkan et al. | May 1985 | A |
| 4550276 | Callahan et al. | Oct 1985 | A |
| 4576616 | Mottram et al. | Mar 1986 | A |
| 4612928 | Tiep et al. | Sep 1986 | A |
| 4627860 | Rowland | Dec 1986 | A |
| 4630482 | Traina | Dec 1986 | A |
| 4681099 | Sato et al. | Jul 1987 | A |
| 4698075 | Dechene | Oct 1987 | A |
| 4813979 | Miller et al. | Mar 1989 | A |
| 4857086 | Kawai | Aug 1989 | A |
| 4859217 | Chao | Aug 1989 | A |
| 4892566 | Bansal et al. | Jan 1990 | A |
| 4925464 | Rabenau et al. | May 1990 | A |
| 4927434 | Cordes et al. | May 1990 | A |
| 4938066 | Dorr | Jul 1990 | A |
| 4938212 | Snook et al. | Jul 1990 | A |
| 4968329 | Keefer | Nov 1990 | A |
| 4971049 | Rotariu et al. | Nov 1990 | A |
| 4971609 | Pawlos | Nov 1990 | A |
| 4973339 | Bansal | Nov 1990 | A |
| 4986269 | Hakkinen | Jan 1991 | A |
| 5004485 | Hamlin et al. | Apr 1991 | A |
| 5005571 | Dietz | Apr 1991 | A |
| 5024219 | Dietz | Jun 1991 | A |
| 5048515 | Sanso | Sep 1991 | A |
| 5052400 | Dietz | Oct 1991 | A |
| 5060506 | Douglas | Oct 1991 | A |
| 5060514 | Aylsworth | Oct 1991 | A |
| 5069221 | Smith | Dec 1991 | A |
| 5069688 | Wells | Dec 1991 | A |
| 5082473 | Keefer | Jan 1992 | A |
| 5099193 | Moseley et al. | Mar 1992 | A |
| 5099837 | Russel et al. | Mar 1992 | A |
| 5108467 | Schroter et al. | Apr 1992 | A |
| 5129924 | Schultz | Jul 1992 | A |
| 5146918 | Kallok et al. | Sep 1992 | A |
| 5176721 | Hay et al. | Jan 1993 | A |
| 5223004 | Eteve et al. | Jun 1993 | A |
| 5226933 | Knaebel et al. | Jul 1993 | A |
| 5268021 | Hill et al. | Dec 1993 | A |
| 5275642 | Bassine | Jan 1994 | A |
| 5315990 | Mondry | May 1994 | A |
| 5340381 | Vorih | Aug 1994 | A |
| 5351522 | Lura | Oct 1994 | A |
| 5378345 | Taylor et al. | Jan 1995 | A |
| 5469372 | McBrearty et al. | Nov 1995 | A |
| 5470378 | Kandybin et al. | Nov 1995 | A |
| 5474595 | McCombs | Dec 1995 | A |
| 5479932 | Higgins | Jan 1996 | A |
| 5503146 | Froehlich et al. | Apr 1996 | A |
| 5549720 | Miller et al. | Aug 1996 | A |
| 5575282 | Knoch et al. | Nov 1996 | A |
| 5578115 | Cole | Nov 1996 | A |
| 5593478 | Hill et al. | Jan 1997 | A |
| 5603315 | Sasso | Feb 1997 | A |
| 5672195 | Moreau et al. | Sep 1997 | A |
| 5682877 | Mondry | Nov 1997 | A |
| 5690098 | Ottestad et al. | Nov 1997 | A |
| 5697364 | Chua et al. | Dec 1997 | A |
| 5730778 | Hill et al. | Mar 1998 | A |
| 5733359 | Doong et al. | Mar 1998 | A |
| 5735268 | Chua et al. | Apr 1998 | A |
| 5746806 | Aylsworth et al. | May 1998 | A |
| 5764534 | Goetting | Jun 1998 | A |
| 5766310 | Cramer | Jun 1998 | A |
| 5792665 | Morrow | Aug 1998 | A |
| 5827358 | Kulish et al. | Oct 1998 | A |
| 5839434 | Enterline | Nov 1998 | A |
| 5858062 | McCulloh et al. | Jan 1999 | A |
| 5858063 | Cao et al. | Jan 1999 | A |
| 5865174 | Kloeppel | Feb 1999 | A |
| 5890490 | Aylsworth et al. | Apr 1999 | A |
| 5893944 | Dong | Apr 1999 | A |
| 5906672 | Michaels et al. | May 1999 | A |
| 5913307 | Taieb et al. | Jun 1999 | A |
| 5917135 | Michaels et al. | Jun 1999 | A |
| 5922107 | Labasque et al. | Jul 1999 | A |
| 5928189 | Phillips et al. | Jul 1999 | A |
| 5957133 | Hart | Sep 1999 | A |
| 5961694 | Monereau et al. | Oct 1999 | A |
| 5968236 | Bassine | Oct 1999 | A |
| 5988465 | Vitale et al. | Nov 1999 | A |
| 5997617 | Czabala et al. | Dec 1999 | A |
| 6017315 | Starr et al. | Jan 2000 | A |
| 6030435 | Monereau et al. | Feb 2000 | A |
| 6065473 | McCombs et al. | May 2000 | A |
| 6068680 | Kulish et al. | May 2000 | A |
| 6099481 | Daniels | Aug 2000 | A |
| 6156101 | Naheiri et al. | Dec 2000 | A |
| 6186142 | Schmidt et al. | Feb 2001 | B1 |
| 6186477 | McCombs et al. | Feb 2001 | B1 |
| 6192883 | Miller | Feb 2001 | B1 |
| 6220244 | McLaughlin | Apr 2001 | B1 |
| 6238458 | Monereau | May 2001 | B1 |
| 6253767 | Mantz | Jul 2001 | B1 |
| 6302107 | Richey et al. | Oct 2001 | B1 |
| 6314957 | Boissin et al. | Nov 2001 | B1 |
| 6342040 | Starr et al. | Jan 2002 | B1 |
| 6346139 | Czabala | Feb 2002 | B1 |
| 6371114 | Schmidt et al. | Apr 2002 | B1 |
| 6371117 | Lindqvist et al. | Apr 2002 | B1 |
| 6382931 | Czabala et al. | May 2002 | B1 |
| 6394089 | Cantrill et al. | May 2002 | B1 |
| 6395065 | Murdoch et al. | May 2002 | B1 |
| 6418782 | Sato et al. | Jul 2002 | B1 |
| 6427690 | McCombs et al. | Aug 2002 | B1 |
| 6446630 | Todd, Jr. | Sep 2002 | B1 |
| 6478850 | Warren | Nov 2002 | B1 |
| 6478857 | Czabala | Nov 2002 | B2 |
| 6484721 | Bliss | Nov 2002 | B1 |
| 6506234 | Ackley et al. | Jan 2003 | B1 |
| 6511526 | Jagger et al. | Jan 2003 | B2 |
| 6514318 | Keefer | Feb 2003 | B2 |
| 6520176 | Dubois et al. | Feb 2003 | B1 |
| 6527830 | Neu et al. | Mar 2003 | B1 |
| 6532958 | Buan et al. | Mar 2003 | B1 |
| 6536431 | Simler | Mar 2003 | B1 |
| 6547851 | Warren | Apr 2003 | B2 |
| 6551384 | Ackley et al. | Apr 2003 | B1 |
| 6558451 | McCombs et al. | May 2003 | B2 |
| 6561187 | Schmidt et al. | May 2003 | B2 |
| 6605136 | Graham et al. | Aug 2003 | B1 |
| 6629525 | Hill et al. | Oct 2003 | B2 |
| 6651658 | Hill et al. | Nov 2003 | B1 |
| 6655383 | Lundberg | Dec 2003 | B1 |
| 6669758 | Hart et al. | Dec 2003 | B1 |
| 6691702 | Appel et al. | Feb 2004 | B2 |
| 6694973 | Dunhao et al. | Feb 2004 | B1 |
| 6698423 | Honkonen et al. | Mar 2004 | B1 |
| 6699307 | Lomax | Mar 2004 | B1 |
| 6702880 | Roberts et al. | Mar 2004 | B2 |
| 6712876 | Cao et al. | Mar 2004 | B2 |
| 6712877 | Cao et al. | Mar 2004 | B2 |
| 6749405 | Bassine | Jun 2004 | B2 |
| 6755895 | Lomax et al. | Jun 2004 | B2 |
| 6764534 | McCombs et al. | Jul 2004 | B2 |
| 6790260 | Ackley et al. | Sep 2004 | B2 |
| 6802889 | Graham et al. | Oct 2004 | B2 |
| 6824590 | Dee et al. | Nov 2004 | B2 |
| 6827760 | Kutt et al. | Dec 2004 | B2 |
| 6837244 | Yagi et al. | Jan 2005 | B2 |
| 6866041 | Hardy et al. | Mar 2005 | B2 |
| 6866950 | Connor et al. | Mar 2005 | B2 |
| 6896721 | Lynn | May 2005 | B1 |
| 6908503 | McCombs et al. | Jun 2005 | B2 |
| 6918953 | Lomax et al. | Jul 2005 | B2 |
| 6929683 | Lomax et al. | Aug 2005 | B2 |
| 6935460 | McCombs et al. | Aug 2005 | B2 |
| 6938619 | Hickle | Sep 2005 | B1 |
| 6949133 | McCombs et al. | Sep 2005 | B2 |
| 6981502 | McCormick et al. | Jan 2006 | B2 |
| 6990975 | Jones et al. | Jan 2006 | B1 |
| 7000612 | Jafari et al. | Feb 2006 | B2 |
| 7007694 | Aylsworth et al. | Mar 2006 | B2 |
| 7011092 | McCombs et al. | Mar 2006 | B2 |
| 7013898 | Rashad et al. | Mar 2006 | B2 |
| 7037358 | Babicki et al. | May 2006 | B2 |
| 7059323 | Kullik et al. | Jun 2006 | B2 |
| 7066985 | Deane et al. | Jun 2006 | B2 |
| 7077133 | Yagi et al. | Jul 2006 | B2 |
| 7105038 | Lee et al. | Sep 2006 | B2 |
| 7114932 | Bassine | Oct 2006 | B1 |
| 7121276 | Jagger et al. | Oct 2006 | B2 |
| 7122073 | Notaro et al. | Oct 2006 | B1 |
| 7135059 | Deane et al. | Nov 2006 | B2 |
| 7156903 | McCombs | Jan 2007 | B2 |
| 7171963 | Jagger et al. | Feb 2007 | B2 |
| 7178563 | Richey et al. | Feb 2007 | B2 |
| 7179326 | Nakamura et al. | Feb 2007 | B2 |
| 7204249 | Richey et al. | Apr 2007 | B1 |
| 7213468 | Fujimoto | May 2007 | B2 |
| 7222624 | Rashad et al. | May 2007 | B2 |
| 7225809 | Bowen et al. | Jun 2007 | B1 |
| 7279029 | Occhialini et al. | Oct 2007 | B2 |
| 7306657 | Yagi et al. | Dec 2007 | B2 |
| 7329304 | Bliss et al. | Feb 2008 | B2 |
| 7329354 | Mullee | Feb 2008 | B2 |
| 7396390 | Hayashi et al. | Jul 2008 | B2 |
| 7402193 | Bliss et al. | Jul 2008 | B2 |
| 7431032 | Jagger et al. | Oct 2008 | B2 |
| 7438745 | Deane et al. | Oct 2008 | B2 |
| 7473299 | Occhialini et al. | Jan 2009 | B2 |
| 7556038 | Kirby | Jul 2009 | B2 |
| 7565907 | Curti et al. | Jul 2009 | B2 |
| 7582138 | Lessi et al. | Sep 2009 | B2 |
| 7585351 | Deane et al. | Sep 2009 | B2 |
| 7604004 | Jagger et al. | Oct 2009 | B2 |
| 7604005 | Jagger et al. | Oct 2009 | B2 |
| 7686870 | Deane et al. | Mar 2010 | B1 |
| 7708802 | Deane et al. | May 2010 | B1 |
| 7730887 | Deane et al. | Jun 2010 | B2 |
| 7753996 | Deane et al. | Jul 2010 | B1 |
| 7757693 | Toussaint | Jul 2010 | B2 |
| 7766010 | Jagger et al. | Aug 2010 | B2 |
| 7780768 | Taylor et al. | Aug 2010 | B2 |
| 7814906 | Moretti | Oct 2010 | B2 |
| 7837761 | Bliss et al. | Nov 2010 | B2 |
| 7841343 | Deane et al. | Nov 2010 | B2 |
| 7857894 | Taylor et al. | Dec 2010 | B2 |
| 7866315 | Jagger et al. | Jan 2011 | B2 |
| 7922789 | Deane et al. | Apr 2011 | B1 |
| 8016918 | LaBuda et al. | Sep 2011 | B2 |
| 8020558 | Christopher et al. | Sep 2011 | B2 |
| 8142544 | Taylor et al. | Mar 2012 | B2 |
| 8147597 | Dolensky et al. | Apr 2012 | B2 |
| 20010004893 | Biondi | Jun 2001 | A1 |
| 20010020603 | Moorehead et al. | Sep 2001 | A1 |
| 20020038657 | Yagi | Apr 2002 | A1 |
| 20030006024 | Wang | Jan 2003 | A1 |
| 20030111081 | Gupta | Jun 2003 | A1 |
| 20030140924 | Aylsworth et al. | Jul 2003 | A1 |
| 20040050255 | Simonds | Mar 2004 | A1 |
| 20040074496 | Hayashi et al. | Apr 2004 | A1 |
| 20040141874 | Mullinax | Jul 2004 | A1 |
| 20040159323 | Schmidt et al. | Aug 2004 | A1 |
| 20040182394 | Alvey et al. | Sep 2004 | A1 |
| 20050027216 | Guillemaud | Feb 2005 | A1 |
| 20050066976 | Wondka | Mar 2005 | A1 |
| 20050103341 | Deane | May 2005 | A1 |
| 20050103343 | Gosweiler | May 2005 | A1 |
| 20050121033 | Starr et al. | Jun 2005 | A1 |
| 20050160905 | Whitley et al. | Jul 2005 | A1 |
| 20050192538 | Voege | Sep 2005 | A1 |
| 20050217674 | Burton et al. | Oct 2005 | A1 |
| 20060084877 | Ujhazy et al. | Apr 2006 | A1 |
| 20060102181 | McCombs et al. | May 2006 | A1 |
| 20060112962 | Tebbutt et al. | Jun 2006 | A1 |
| 20060117957 | McCombs | Jun 2006 | A1 |
| 20060144240 | Lee et al. | Jul 2006 | A1 |
| 20060174871 | Jagger | Aug 2006 | A1 |
| 20060174875 | Jagger et al. | Aug 2006 | A1 |
| 20060174876 | Jagger et al. | Aug 2006 | A1 |
| 20060174877 | Jagger et al. | Aug 2006 | A1 |
| 20060174880 | Jagger et al. | Aug 2006 | A1 |
| 20060174881 | Jagger et al. | Aug 2006 | A1 |
| 20060174882 | Jagger et al. | Aug 2006 | A1 |
| 20060185668 | Jagger et al. | Aug 2006 | A1 |
| 20060207594 | Stenzler et al. | Sep 2006 | A1 |
| 20060230931 | Bliss et al. | Oct 2006 | A1 |
| 20060230939 | Bliss et al. | Oct 2006 | A1 |
| 20060266357 | McCombs et al. | Nov 2006 | A1 |
| 20070039466 | Nawata et al. | Feb 2007 | A1 |
| 20070044799 | Hete et al. | Mar 2007 | A1 |
| 20070056583 | Jagger et al. | Mar 2007 | A1 |
| 20070056584 | Jagger et al. | Mar 2007 | A1 |
| 20070137487 | Whitley et al. | Jun 2007 | A1 |
| 20070169623 | Lee et al. | Jul 2007 | A1 |
| 20070227539 | Schwaibold et al. | Oct 2007 | A1 |
| 20070283958 | Naghavi | Dec 2007 | A1 |
| 20070293781 | Sims | Dec 2007 | A1 |
| 20080053441 | Gottlib et al. | Mar 2008 | A1 |
| 20080066741 | Lemahieu et al. | Mar 2008 | A1 |
| 20080078392 | Pelletier et al. | Apr 2008 | A1 |
| 20080103404 | Cao | May 2008 | A1 |
| 20080110462 | Chekal | May 2008 | A1 |
| 20080202508 | McClain et al. | Aug 2008 | A1 |
| 20080223367 | Cox et al. | Sep 2008 | A1 |
| 20080302364 | Garde et al. | Dec 2008 | A1 |
| 20090065007 | Wilkinson | Mar 2009 | A1 |
| 20090065526 | Sprinkle | Mar 2009 | A1 |
| 20090107500 | Edwards | Apr 2009 | A1 |
| 20090107501 | Krieger | Apr 2009 | A1 |
| 20090133699 | Nalagatla et al. | May 2009 | A1 |
| 20090145428 | Sward et al. | Jun 2009 | A1 |
| 20090199855 | Davenport | Aug 2009 | A1 |
| 20090211438 | Thompson et al. | Aug 2009 | A1 |
| 20090211448 | McClain | Aug 2009 | A1 |
| 20090241956 | Baker et al. | Oct 2009 | A1 |
| 20090306529 | Curti et al. | Dec 2009 | A1 |
| 20100051030 | Richard et al. | Mar 2010 | A1 |
| 20100071698 | Kiritake | Mar 2010 | A1 |
| 20100076514 | Cho | Mar 2010 | A1 |
| 20100094366 | McCarthy | Apr 2010 | A1 |
| 20100116270 | Edwards et al. | May 2010 | A1 |
| 20100133900 | King | Jun 2010 | A1 |
| 20100282084 | Taylor et al. | Nov 2010 | A1 |
| 20100313898 | Richard et al. | Dec 2010 | A1 |
| 20110017063 | Van Brunt et al. | Jan 2011 | A1 |
| 20110017216 | Van Brunt et al. | Jan 2011 | A1 |
| 20110020143 | Van Brunt et al. | Jan 2011 | A1 |
| 20110020156 | Van Brunt et al. | Jan 2011 | A1 |
| 20110030684 | Wilkinson et al. | Feb 2011 | A1 |
| 20110030685 | Wilkinson et al. | Feb 2011 | A1 |
| 20110030686 | Wilkinson et al. | Feb 2011 | A1 |
| 20110030687 | Wilkinson et al. | Feb 2011 | A1 |
| 20110030689 | Wilkinson et al. | Feb 2011 | A1 |
| 20110046498 | Klap | Feb 2011 | A1 |
| 20110186054 | Boyd | Aug 2011 | A1 |
| 20110232483 | Haberland et al. | Sep 2011 | A1 |
| 20110247620 | Armstrong et al. | Oct 2011 | A1 |
| 20110303223 | Kane | Dec 2011 | A1 |
| 20110315140 | Shuman | Dec 2011 | A1 |
| 20120029307 | Paquet | Feb 2012 | A1 |
| 20120055340 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055474 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055475 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055477 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055478 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055480 | Wilkinson et al. | Mar 2012 | A1 |
| 20120055482 | Wilkinson | Mar 2012 | A1 |
| 20120055483 | Wilkinson et al. | Mar 2012 | A1 |
| 20120167883 | Taylor et al. | Jul 2012 | A1 |
| 20120167886 | Taylor et al. | Jul 2012 | A1 |
| 20120167887 | Taylor et al. | Jul 2012 | A1 |
| 20120167888 | Taylor et al. | Jul 2012 | A1 |
| 20120203128 | Levison | Aug 2012 | A1 |
| 20120266883 | Taylor et al. | Oct 2012 | A1 |
| 20130172759 | Melker | Jul 2013 | A1 |
| 20140137737 | Wilkinson et al. | May 2014 | A1 |
| 20140137744 | Wilkinson et al. | May 2014 | A1 |
| 20150059742 | Wilkinson et al. | Mar 2015 | A1 |
| Number | Date | Country |
|---|---|---|
| 0978477 | Feb 2000 | EP |
| 1205231 | May 2002 | EP |
| 1568391 | Aug 2005 | EP |
| 1661596 | May 2006 | EP |
| H07-172804 | Jul 1995 | JP |
| 2000354630 | Dec 2000 | JP |
| 2002253675 | Sep 2002 | JP |
| 2005087937 | Apr 2005 | JP |
| 2005245825 | Sep 2005 | JP |
| 2006095285 | Apr 2006 | JP |
| 2007195820 | Aug 2007 | JP |
| 4816590 | Nov 2011 | JP |
| 10-0741307 | Jul 2007 | KR |
| 9922795 | May 1999 | WO |
| 9943416 | Sep 1999 | WO |
| 0249742 | Jun 2002 | WO |
| 2006108092 | Oct 2006 | WO |
| Entry |
|---|
| Search Report/Written Opinion for PCT Application No. PCT/US2013/064810 issued on Feb. 7, 2014. |
| Search Report/Written Opinion for PCT Application No. PCT/US2013/064817 issued on Jan. 10, 2014. |
| Search Report/Written Opinion for PCT Application No. PCT/US2013/064823 issued on Jan. 22, 2014. |
| Japanese Examination Report for JP Application No. 2010-524089 issued Apr. 22, 2013. |
| Japanese Examination Report for JP Application No. 2010-524089 issued Mar. 4, 2014. |
| EP Communication for EP Application No. 2197530 issued May 24, 2012. |
| EP Communication for EP Application No. 2197530 issued Feb. 5, 2014. |
| Australian Examination Report for Australian Patent Application No. 2008296606 issued Jul. 11, 2014. |
| Search Report for EP Application No. 2613838 issued Apr. 17, 2013. |
| EP Communication for EP Application No. 2613838 issued Mar. 17, 2015. |
| Office Action for U.S. Appl. No. 12/163,549 issued Aug. 14, 2013. |
| Office Action for U.S. Appl. No. 12/163,549 issued Dec. 20, 2013. |
| Office Action for U.S. Appl. No. 12/868,340 issued Apr. 26, 2013. |
| Office Action for U.S. Appl. No. 12/868,340 issued Nov. 7, 2013. |
| Office Action for U.S. Appl. No. 12/868,340 issued May 22, 2014. |
| Office Action for U.S. Appl. No. 12/868,354 issued Apr. 26, 2013. |
| Office Action for U.S. Appl. No. 12/868,354 issued Mar. 6, 2014. |
| Office Action for U.S. Appl. No. 12/868,354 issued Nov. 6, 2014. |
| Office Action for U.S. Appl. No. 12/868,368 issued Apr. 26, 2013. |
| Office Action for U.S. Appl. No. 12/868,368 issued Jan. 17, 2014. |
| Office Action for U.S. Appl. No. 12/868,368 issued Aug. 7, 2014. |
| Office Action for U.S. Appl. No. 12/868,368 issued Dec. 19, 2014. |
| Office Action for U.S. Appl. No. 12/868,382 issued May 22, 2013. |
| Office Action for U.S. Appl. No. 12/868,391 issued May 23, 2013. |
| Office Action for U.S. Appl. No. 12/876,848 issued Oct. 26, 2012. |
| Office Action for U.S. Appl. No. 12/876,848 issued May 23, 2013. |
| Office Action for U.S. Appl. No. 12/876,854 issued Jul. 18, 2013. |
| Office Action for U.S. Appl. No. 12/876,854 issued Feb. 14, 2014. |
| Office Action for U.S. Appl. No. 12/876,878 issued Jun. 19, 2013. |
| Office Action for U.S. Appl. No. 12/876,878 issued Feb. 5, 2014. |
| Office Action for U.S. Appl. No. 12/876,878 issued Nov. 20, 2014. |
| Office Action for U.S. Appl. No. 12/876,874 issued Feb. 15, 2013. |
| Office Action for U.S. Appl. No. 12/876,882 issued Jul. 30, 2013. |
| Office Action for U.S. Appl. No. 12/876,882 issued Oct. 8, 2014. |
| Office Action for U.S. Appl. No. 12/876,890 issued Aug. 16, 2013. |
| Office Action for U.S. Appl. No. 12/876,890 issued Mar. 12, 2014. |
| Office Action for U.S. Appl. No. 12/876,890 issued Nov. 28, 2014. |
| Office Action for U.S. Appl. No. 12/876,899 issued Aug. 19, 2013. |
| Office Action for U.S. Appl. No. 12/876,899 issued Aug. 28, 2014. |
| Office Action for U.S. Appl. No. 12/876,899 issued May 5, 2015. |
| Office Action for U.S. Appl. No. 14/053,029 issued Sep. 24, 2014. |
| Office Action for U.S. Appl. No. 14/053,029 issued Mar. 12, 2015. |
| Bonnema, Lisa. “Breathing Easy with Plastic Blends”; http://www.appliancemagazine. com/editorial.php?articl=927&zibe=211&first=1; issue: Apr. 2005 Appliance Magazine; downloaded on Jul. 26, 2007. |
| Freesyle; FreeStyleTM Portable Oxygen Concentrator, Patient Manual, AirSep, Revision; Jan. 27, 2006. |
| Lifestyle; Lifestyle TM Portable Oxygen Concentrator, Patient Manual, AirSep, Revision Date Dec. 2004. |
| Yang, Ralph T., “Gas Separation by Adsorption Processes”, Imperial College Press, 1987, pp. 141-200. |
| Hartzog, D. G. and Sircar, S., “Sensitivity of PSA Process Performance to Input Variables”, Adsorption 1, 133-151 (1995). |
| Keller II, George E., et al., “A New Process for Adsorption Separation of Gas Streams”, ACS Symposium Series 135, 1980, pp. 275-286. |
| “Pressure Swing Adsorption” Douglas Morris Ruthven, Shamsuzzaman Farooq, and Kent S. Knaebel; VCH Publishers, 1994—Science. |
| Kopaygorodsky et al. “Scaling Analysis—A Valuable Technique in Engineering Teaching and Practice” Proceedings of the 2001 American Society for Engineering Education Annual Conference & Exposition Session 3513, 2001. |
| Tiep “Long-Term Home Oxygen Therapy”, Clinics in Chest Medicine, Sep. 1990, vol. 11, No. 3, pp. 505-521. |
| Dietz “international Society for Mountain Medicine: An Altitude Tutorial” Jan. 29, 2006, pp. 1-12. |
| Kumar, R., et al., “A Versatile Process Simulator for Adsorptive Separations”, Chemical Engineering Science, vol. 49, No. 18, pp. 3115-3125. |
| Search Report for PCT Application No. PCT/US2008/073884 issued on Mar. 10, 2009. |
| Written Opinion for PCT Application No. PCT/US2008/073884 issued on Mar. 10, 2009. |
| International Preliminary Report on Patentability for PCT Application No. PCT/US2008/073884 issued on Mar. 18, 2010. |
| Search Report for EP Application No. 2197530 issued Aug. 8, 2011. |
| Search Report/Written Opinion for PCT Application No. PCT/US2011/050700 issued on May 1, 2012. |
| Australian Examination Report for Australian Patent Application No. 2008296606 issued Mar. 27, 2013. |
| Office Action for U.S. Appl. No. 12/163,549 issued May 10, 2012. |
| Office Action for U.S. Appl. No. 12/868,340 issued Oct. 10, 2012. |
| Office Action for U.S. Appl. No. 12/868,354 issued Oct. 11, 2012. |
| Office Action for U.S. Appl. No. 12/868,368 issued Oct. 5, 2012. |
| Office Action for U.S. Appl. No. 12/868,382 issued Oct. 12, 2012. |
| Office Action for U.S. Appl. No. 12/868,391 issued Oct. 5, 2012. |
| Office Action for U.S. Appl. No. 12/876,854 issued Nov. 28, 2012. |
| Office Action for U.S. Appl. No. 12/876,878 issued Nov. 9, 2012. |
| Office Action for U.S. Appl. No. 12/876,874 issued Aug. 22, 2012. |
| Office Action for U.S. Appl. No. 12/876,882 issued Dec. 6, 2012. |
| Office Action for U.S. Appl. No. 12/876,884 issued Nov. 13, 2012. |
| Office Action for U.S. Appl. No. 12/876,890 issued Nov. 26, 2012. |
| Office Action for U.S. Appl. No. 12/876,899 issued Dec. 21, 2012. |
| Number | Date | Country | |
|---|---|---|---|
| 20140137859 A1 | May 2014 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61713254 | Oct 2012 | US | |
| 61804365 | Mar 2013 | US |
